Atom Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Atom Investors's BMY Position: Q2 2026 in Review
Atom Investors reduced its Bristol-Myers Squibb (BMY) stake by 55% in Q2 2026, selling an estimated $3.96M and leaving 55,638 shares worth $3.21M. The position accounts for 0.29% of the portfolio, ranked #70.
Atom Investors first reported a position in BMY in Q3 2020 and has held it in 8 quarters since. The position peaked at $7.55M in Q1 2026. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Atom Investors held 55,638 shares of Bristol-Myers Squibb worth $3.21M as of Q2 2026.
- Atom Investors sold 68,887 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.96M.
- Bristol-Myers Squibb made up 0.29% of Atom Investors's portfolio in Q2 2026, its #70 holding.
- Atom Investors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 8 quarters since.
- Atom Investors's Bristol-Myers Squibb position peaked at $7.55M in Q1 2026.
- 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.